Briacell Therapeutics Corp. Common Shares BCTX
$3.45
-1.43%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-30,976,383
- Net Margin
- —
- Return on Equity
- -132.33%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 1.30
- Price / Sales
- —
Over the trailing twelve months, Briacell Therapeutics Corp. Common Shares generated revenue of — and net income of $-30,976,383.
Key Stats
- Last Close
- $3.45
- Market Cap
- $30.45 million
- 52-Week Range
- $2.60 – $30.00
- Average Volume
- 149K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.